Skip to content
2000
Volume 21, Issue 17
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Curcuma longa has been mentioned in the Indian system of medicine for the management of a wide range of diseases. C. longa and its metabolites like curcumin, ar-turmerone, methylcurcumin, demethoxy-curcumin, and bisdemethoxycurcumin have also been reported to be beneficial in various types of cancer. Curcumin elicits anticancer properties chiefly by triggering apoptotic pathways in cancer cells. The properties are facilitated through diverse signaling pathways viz. pathways mediated by NF-kB, WNT/β-catenin pathway COX-2, LOX, STAT3, prostaglandin E2, phosphorylase kinase, VEGF, AKT, AP1, STAT3, PI3K, Akt, mTOR, ERK5, AP-1, TGF-b, PPARc, EBPa, NLRP3 inflammasome, p38MAPK, Nrf2, Notch-1, AMPK, TLR-4, etc. The present article highlights curcumin biosynthesis, phytochemistry and diverse molecular pathways involved in regulating several types of secondary messengers to exhibit anticancer activity in almost all the forms of cancer.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557521666210122153823
2021-10-01
2025-07-10
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557521666210122153823
Loading

  • Article Type:
    Review Article
Keyword(s): apoptosis; cancer; curcuma longa; Curcumin; molecular pathways; phytochemistry
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test